omission of axillary dissection

PROCEDURE2 trials

Sponsors

Department of Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Istituto Clinico Humanitas

Conditions

Breast Cancerpatients with one sentinel-node macro-metastasis who undergo total mastectomy

Unknown Phase

Omission of axillary lymph node dissection in patients with clinically negative but pathologically positive sentinel-node macro-metastasis who undergo total mastectomy

Active, not recruitingJPRN-UMIN000036897

Department of Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Researchpatients with one sentinel-node macro-metastasis who undergo total mastectomy

Start: 2019-05-30Target: 180Updated: 2026-09-14

Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.

RecruitingNCT04019678

Istituto Clinico HumanitasBreast Cancer

Start: 2019-06-21End: 2027-06-21Target: 850Updated: 2021-04-19

Related Papers

Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy

BMC Cancer2022-11-169 citations